Laansma, M.A.; Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
Bright, J.K.; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States
Al-Bachari, S.; Faculty of Health and Medicine, The University of Lancaster, Lancaster, United Kingdom, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, Department of Neurology, Royal Preston Hospital, Preston, United Kingdom
Anderson, T.J.; Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand
Ard, T.; Department of Neurology, USC Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, United States
Assogna, F.; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
Berendse, H.W.; Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Blair, J.; Department of Medical Imaging, University of Virginia Health System, Charlottesville, VA, United States
Cendes, F.; Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, Brazil
Dalrymple-Alford, J.C.; New Zealand Brain Research Institute, Christchurch, New Zealand, School of Psychology, Speech and Hearing, University of Canterbury, Christchurch, New Zealand, Brain Research New Zealand - Rangahau Roro Aotearoa, Centre of Research Excellence, Auckland, New Zealand
de Bie, R.M.A.; Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Debove, I.; Department of Neurology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland
Dirkx, M.F.; Department of Neurology and Center of Expertise for Parkinson & Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, Netherlands
Druzgal, J.; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, United States
Emsley, H.C.A.; Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, Lancaster Medical School, Lancaster University, Preston, United Kingdom
Garraux, Gaëtan ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Guimarães, R.P.; Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, Brazil
Gutman, B.A.; Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, United States
Helmich, R.C.; Department of Neurology and Center of Expertise for Parkinson & Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, Netherlands
Klein, J.C.; Department of Clinical Neurosciences, Division of Clinical Neurology, Oxford Parkinson's Disease Centre, Nuffield, University of Oxford, Oxford, United Kingdom
Mackay, C.E.; Department of Psychiatry, University of Oxford, Oxford, United Kingdom
McMillan, C.T.; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States
Melzer, T.R.; Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, New Zealand Brain Research Institute, Christchurch, New Zealand, Brain Research New Zealand - Rangahau Roro Aotearoa, Centre of Research Excellence, Auckland, New Zealand
Parkes, L.M.; Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom
Piras, F.; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
Pitcher, T.L.; Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, New Zealand Brain Research Institute, Christchurch, New Zealand, Brain Research New Zealand - Rangahau Roro Aotearoa, Centre of Research Excellence, Auckland, New Zealand
Poston, K.L.; Department of Neurology & Neurological Sciences, Stanford University, Palo Alto, CA, United States
Rango, M.; Excellence Center for Advanced MR Techniques and Parkinson's Disease Center, Neurology Unit, Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan, Milan, Italy
Ribeiro, L.F.; Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, Brazil
Rocha, C.S.; Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, Brazil, Department of Medical Genetics, University of Campinas, Campinas, Brazil
Rummel, C.; Support Center for Advanced Neuroimaging (SCAN), University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Bern, Switzerland
Santos, L.S.R.; Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, Brazil
Schmidt, R.; Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Graz, Austria
Schwingenschuh, P.; Department of Neurology, Medical University of Graz, Graz, Austria
Spalletta, G.; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy
Squarcina, L.; Excellence Center for Advanced MR Techniques and Parkinson's Disease Center, Neurology Unit, Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan, Milan, Italy
van den Heuvel, O.A.; Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands, Psychiatry, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
Wang, J.-J.; Department of Medical Imaging and Radiological Sciences, Chang Gung University, Taoyuan City, Taiwan, Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Keelung Branch, Keelung City, Taiwan
Weintraub, D.; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States
Wiest, R.; Support Center for Advanced Neuroimaging (SCAN), University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Bern, Switzerland
Yasuda, C.L.; Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, Brazil
Jahanshad, N.; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States
Thompson, P.M.; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, United States
van der Werf, Y.D.; Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease
Publication date :
2021
Journal title :
Movement Disorders
ISSN :
0885-3185
eISSN :
1531-8257
Publisher :
John Wiley and Sons Inc
Volume :
36
Issue :
11
Pages :
2583 - 2594
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
Y.D.v.d.W.: none. M.A.L.: none. J.K.B.: none. S.A.: grant from the Dowager Countess Eleanor Peel Trust Medical Research Grant. T.J.A.: none. T.A.: grants from Alzheimer's Disease Neuroimaging Initiative (U01AG02490), Neurodegeneration in Aging Down Syndrome (U01AG051406). F.A.: none. K.A.B.: none. H.W.B.: grants from ZonMw, Michael J. Fox Foundation. J.B.: none. F.C.: Employment at National Council for Scientific and Technological Development (CNPq). J.C.D.: grants from New Zealand Neurological Foundation, Health Research Council of New Zealand, Brain Research New Zealand, School of Psychology, Speech and Hearing. R.M.A.d.B.: research support paid to the institution from Medtronic, Lysosomal Therapeutics, Neuroderm, ZonMw, Parkinson Vereniging, Stichting Parkinson Nederland. I.D.: grants from Boston Scientific, AbbVie, Medtronic, UCB, Bial. Reimbursement: Zambon, Boston Scientific. M.F.D.: none. J.D.: none. H.C.A.E.: grants from NIHR, EPSRC, MRC. G.G.: none. R.P.G.: Employment at National Council for Scientific and Technological Development (CNPq). B.A.G.: grant from Alzheimer's Association Grant 2018‐AARG‐592081. R.C.H.: grants from the Michael J. Fox Foundation (grants 16048 and 15581), Netherlands Organization for Scientific Research (VENI grant 91617077). J.C.K.: none. C.E.M.: none. C.T.M.: none. T.R.M.: none. L.M.P.: grants from Alzheimer's Society, EPSRC UK, EU. F.P.: grants from Italian Ministry of Health RC 19, RC 20. T.L.P.: grant from New Zealand Brain Research Institute; honorarium from Stata Australia Ltd. K.L.P.: grants from the Michael J. Fox Foundation for Parkinson's Research, NIH; honoraria from invited scientific presentations to universities and professional societies not exceeding $5000/year; reimbursement from Sanofi, AstraZeneca, Sangamo BioSciences; consultancies from Allergan, Curasen. M.R.: none. L.F.R.: employment at National Council for Scientific and Technological Development (CNPq). C.S.R.: employment at National Council for Scientific and Technological Development (CNPq). C.R.: grants from Swiss National Science Foundation (projects CRSK‐3_190817/1 and CRSII5_180365), Novartis AG (FreeNovation research grant). L.S.R.S.: employment at National Council for Scientific and Technological Development (CNPq). R.S.: none. P.S.: honoraria from AbbVie, GmbH. G.S.: none. L.S.: none. O.A.v.d.H.: VIDI grant from The Netherlands Organization for Health Research (ZonMw; project number: 91717306); consultancy from Lundbeck. C.V.: none. J.W.: grants MOST 109‐2314‐B‐182‐021‐MY3, MOST 109‐2221‐E‐182‐009‐MY3, MOST 106‐2314‐B‐182‐018‐MY3. D.W.: grants from Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Therapeutic Research Initiative (ATRI), Alzheimer's Disease Cooperative Study (ADCS), the International Parkinson and Movement Disorder Society (IPMDS), the National Institute on Aging (NIA); honoraria from Acadia, Aptinyx, CHDI Foundation, Clintrex LLC (Alkahest, Aptinyx, Avanir, Otsuka), Eisai, Enterin, Great Lake Neurotechnologies, Janssen, Sage, Scion, Signant Health, Sunovion, and Vanda. license fee payments from the University of Pennsylvania for the QUIP and QUIP‐RS. R.W.: grants from the Swiss National Science Foundation (projects CRSII5_180365, 320030L_170060), Swiss Personalized Health Network (driver project 2018DRI10), Swiss Innovation Council (project 43087.1 IP‐LS) University of Bern (sitem‐insel Support Funds 2019), Biogen (research project CHE‐TYS‐18‐11,316). C.L.Y.: employment at National Council for Scientific and Technological Development (CNPq). N.J.: grants from Biogen Inc. P.M.T.: NIH grants U01AG024904, R01MH111671.
Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers 2017;3:17013.
Caligiore D, Helmich RC, Hallett M, et al. Parkinson's disease as a system-level disorder. NPJ Parkinsons Dis 2016;2:16025.
de Micco R, Russo A, Tessitore A. Structural MRI in idiopathic Parkinson's disease. Int Rev Neurobiol 2018;141:405–438.
Hall JM, Lewis SJG. Neural correlates of cognitive impairment in Parkinson's disease: a review of structural MRI findings. Int Rev Neurobiol 2019;144:1–28.
Thompson PM, Jahanshad N, Ching CRK, et al. ENIGMA and global neuroscience: a decade of large-scale studies of the brain in health and disease across 43 countries. Transl Psychiatry 2020;10(1):100.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17(5):427–442.
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53(4):695–699.
Marek K, Jennings D, Lasch S, et al. The Parkinson progression marker initiative (PPMI). Prog Neurobiol 2011;95(4):629–635.
Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19(9):1020–1028.
Ho DE, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 2011;42(8):1–28. https://gkingharvardedu/matchit, https://r.iq.harvard.edu/docs/matchit/2.4-18/matchit.pdf
Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31(3):968–980.
Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33(3):341–355.
Barnes J, Ridgway GR, Bartlett J, et al. Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage 2010;53(4):1244–1255.
Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc 2007;82(4):591–605.
Buckner RL, Head D, Parker J, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004;23(2):724–738.
Zhao YJ, Wee HL, Chan Y-H, et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times. Mov Disord 2010;25(6):710–716.
Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23(6):837–844.
Yau Y, Zeighami Y, Baker TE, et al. Network connectivity determines cortical thinning in early Parkinson's disease progression. Nat Commun 2018;9(1):12.
Fereshtehnejad S-M, Zeighami Y, Dagher A, Postuma RB. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression. Brain 2017;140(7):1959–1976.
Boedhoe PSW, Heymans MW, Schmaal L, et al. An empirical comparison of meta- and mega-analysis with data from the ENIGMA obsessive-compulsive disorder working group. Front Neuroinform 2018;12:102.
Pereira JB, Svenningsson P, Weintraub D, et al. Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology 2014;82(22):2017–2025.
Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012;11(8):697–707.
Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR. Visual dysfunction in Parkinson's disease. Brain 2016;139(11):2827–2843.
Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol 2017;13(4):217–231.
Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behav Brain Res 2011;221(2):564–573.
Brooks DJ. Neuroimaging in Parkinson's disease. NeuroRx 2004;1(2):243–254.
Helmich RC, Janssen MJR, Oyen WJG, Bloem BR, Toni I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 2011;69(2):269–281.
Visser E, Keuken MC, Douaud G, et al. Automatic segmentation of the striatum and globus pallidus using MIST: multimodal image segmentation tool. Neuroimage 2016;125:479–497.
Chen Y, Zhu G, Liu D, et al. The morphology of thalamic subnuclei in Parkinson's disease and the effects of machine learning on disease diagnosis and clinical evaluation. J Neurol Sci 2020;411:116721.
Garg A, Appel-Cresswell S, Popuri K, McKeown MJ, Beg MF. Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease. Front Neurosci 2015;9:101.
Braak H, Ghebremedhin E, Rüb U, Bratzke H, del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318(1):121–134.
Kehagia AA, Barker RA, Robbins TW. Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis. Neurodegener Dis 2013;11(2):79–92.
Engelender S, Isacson O. The threshold theory for Parkinson's disease. Trends Neurosci 2017;40(1):4–14.
Adams HHH, Hibar DP, Chouraki V, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci 2016;19(12):1569–1582.
